Vanguard Total Stock Market ETF (VTI)
326.13
-1.79 (-0.55%)
NYSE · Last Trade: Mar 14th, 4:09 AM EDT
Detailed Quote
| Previous Close | 327.92 |
|---|---|
| Open | 329.49 |
| Day's Range | 325.67 - 331.10 |
| 52 Week Range | 236.42 - 344.42 |
| Volume | 6,294,871 |
| Market Cap | 5.37B |
| Dividend & Yield | 3.804 (1.17%) |
| 1 Month Average Volume | 6,940,588 |
Chart
News & Press Releases
The company said in a filing that it may repurchase shares from time to time though the open market, in privately negotiated transactions or other means.
Via Stocktwits · March 13, 2026
Last year, the two were reportedly in talks to acquire the U.S. operations of Pony AI, a Chinese autonomous vehicle company.
Via Stocktwits · March 13, 2026
On the company’s fourth-quarter (Q4) earnings call on Thursday, CEO Linda Marban rejected the possibility that the Deramiocel therapy could receive only a conditional approval.
Via Stocktwits · March 13, 2026
The Cybercab is slated for volume production in April 2026, and is expected to have no steering wheel or pedals.
Via Stocktwits · March 13, 2026
The study also demonstrated complete and durable responses in patients with recurrent intermediate-risk disease, along with encouraging recurrence-free outcomes in high-risk disease, the company said.
Via Stocktwits · March 13, 2026

The Vanguard 0-3 Month Treasury Bill ETF invests in ultra-short U.S. Treasury securities, giving investors a way to earn short-term government yields while keeping interest-rate risk and portfolio volatility low.
Via The Motley Fool · March 12, 2026
For fiscal 2026, the company now expects net sales growth of 6% to 7%, and diluted earnings per share of $28.05 to $28.55, below a Wall Street estimate of $28.58.
Via Stocktwits · March 12, 2026
The company said upon closing of the final transaction with an institutional investor its outstanding debt will be reduced by approximately $37.9 million.
Via Stocktwits · March 12, 2026
For the fourth quarter, the company reported a net loss of $0.62 per share, compared to loss of $0.16 per share in the corresponding quarter of 2024.
Via Stocktwits · March 12, 2026
Roth Capital reiterated a ‘Buy’ rating and $30 price target on FireFly Aerospace (FLY) after the launch.
Via Stocktwits · March 12, 2026
Bloomberg reported on Thursday that the company’s ordering and shipping systems are still offline following a cyberattack, claimed by pro-Iranian digital activist group Handala, on Wednesday.
Via Stocktwits · March 12, 2026
The company said that the all-new R2 will be available in four configurations, namely Performance, Premium and two Standard versions.
Via Stocktwits · March 12, 2026
The investigational gene therapy RGX-202 exhibited a favorable safety profile with no serious adverse events and no evidence of liver injury, the company said.
Via Stocktwits · March 11, 2026
The company said its pilots will visit its California facility later this year to conduct the testing required to validate the aircraft for commercial service.
Via Stocktwits · March 11, 2026
The Wall Street Journal reported that the outage, which began after midnight on the East Coast, has had an impact across Stryker systems.
Via Stocktwits · March 11, 2026
The cloud software company posted Q4 results on Tuesday, with revenue coming in at $79.6 million, higher than consensus estimates of $79.03 million.
Via Stocktwits · March 11, 2026
The Wall Street Journal reported, citing people familiar with the matter, that the Qatari-backed investment fund Irth Capital Management has submitted a bid to take Papa John's private.
Via Stocktwits · March 11, 2026

Vanguard Long-Term Corporate Bond ETF tracks investment-grade debt maturing beyond 10 years, providing exposure to yield and duration.
Via The Motley Fool · March 11, 2026
The company said that it is ready to deploy its new AI platform, Researgency, within 14 days.
Via Stocktwits · March 11, 2026
Strategy purchased a record 2,098.26 Bitcoin on Tuesday using proceeds from its STRC preferred equity program.
Via Stocktwits · March 11, 2026
UiPath’s Short interest has climbed to 15.7%, nearly double mid-December levels, prompting some traders to expect a short squeeze if the earnings report beats expectations.
Via Stocktwits · March 10, 2026
The U.S. Food and Drug Administration is slated to rule on the company’s application seeking approval for Reproxalap by March 16.
Via Stocktwits · March 10, 2026
Barclays increased the price target on the stock to $4 from $3 and kept an ‘Overweight’ rating on the shares.
Via Stocktwits · March 10, 2026
A quibble about the name shows a bias among many investors.
Via The Motley Fool · March 10, 2026
According to an Axios report, this effort will see the companies tapping into underused electricity grid capacity, as part of a new coalition named Utilize.
Via Stocktwits · March 10, 2026
